Pharma Manufacturing

Menu

Newsletters
Subscribe

Newsletters
Subscribe

Follow us on:

Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sector

Home|
Solution Providers|
E-News|
Subscribe|
Resource Directory|
Webinars|
Issue archive

Follow us on:

Home / Industry News / 2012 / Anti-counterfeit Market on Path to Strong Growth

Anti-counterfeit Market on Path to Strong Growth

Source: PharmaManufacturing.com

Oct 31, 2012

SecuringIndustry.com

Show More Content

More News:

Pharma in review: trending stories 12/6/19

12/06/2019

Most popular Pharma Manufacturing stories from the past seven days.
FDA approves first generics of Novartis blockbuster MS drug

12/06/2019

The U.S. FDA has approved three applications for first generics of Gilenya capsules for the treatment of relapsing forms of multiple sclerosis in adults.
Novartis partners with Amazon to boost manufacturing efficiency

12/06/2019

Novartis will work with Amazon’s cloud-computing unit, Amazon Web Services, to make the manufacturing and delivery of new medicines more efficient.
EMA asks pharma to test diabetes drugs for NDMA

12/04/2019

Common diabetes drugs have become the newest target of an ongoing NDMA scare in pharma.
Merck spars with insurers over $1.3B cyberattack

12/04/2019

Merck says that the attack wiped out years of research data, hampered work at facilities and cost the company $1.3 billion in damages.
Biocon and Mylan nab FDA approval for Herceptin biosim

12/03/2019

Co-developed by both companies, Ogivri will be used for the treatment of breast and gastric cancer patients.
AstraZeneca sells more Seroquel rights to Cheplapharm for $42 million

12/03/2019

Cheplapharm now adds the rights in United States and Canada to its recently acquired ones for Seroquel and Seroquel XR in most European markets and Russia.
FDA denies Lexicon appeal of drug rejection

12/03/2019

Lexicon Pharmaceuticals has failed in its efforts to appeal a rejection from the FDA for its diabetes drug, Zynquista.
Astellas to shell out $3 billion in gene therapy takeover

12/03/2019

Japan-based Astellas Pharma is dropping nearly $3 billion in cash to scoop up San Francisco’s Audentes Therapeutics.
Samoan government shuts down over measles outbreak

12/02/2019

The Samoan government will shut down for two days as part of a series of drastic steps being taken to stop a deadly outbreak of measles.

All news

Most Popular

Past 7 Days
Past 30 Days
Past 6 Months

01

Samoan government shuts down over measles outbreak

The Samoan government will shut down for two days as part of a series of…
02

Lilly opens shared innovation lab

Eli Lilly and Company unveiled its first shared innovation lab, located in…
03

EMA asks pharma to test diabetes drugs for NDMA

Common diabetes drugs have become the newest target of an ongoing NDMA…
04

Merck spars with insurers over $1.3B cyberattack

Merck says that the attack wiped out years of research data, hampered work…
05

The future of cold chain logistics

Coming to a supply chain near you

01

Outbreak of a deadly swine fever could trigger global heparin shortage

Heparin, one of the world’s most critical heart medications, could soon…
02

Lonza CEO makes sudden, surprise departure

Lonza investors were reportedly taken aback this week by the surprise…
03

The elephant in the biopharma classroom

Biopharma needs to address its workforce training methods
04

FDA warns Torrent for water system laced with bacteria

The FDA has slapped India-based Torrent Pharmaceuticals with a warning…
05

Samoan government shuts down over measles outbreak

The Samoan government will shut down for two days as part of a series of…

01

2019 Pharma Innovation Awards

This year's winners offer slices of innovation
02

Pharma's budding opportunity

Why the industry is forming bonds with CBD
03

What’s behind all the M&A deals in pharma?

As far as M&A deals go, 2019 has started off with a boom.
04

Making the case for Indian generic drug manufacturing

In response to the growing regulatory environment, pharmaceutical…
05

CDMO trends: Drug development and industry consolidation

How those in the outsourcing sector can be more prepared to meet shifting…

Pharma Manufacturing

About

General Information
Contact Us
Subscription Services
Media Kit
Editorial Calendar
Editorial Submissions Guidelines
Editorial Advisory Board

Content

Resource Libraries
OpEd
Fundamentals
News
Articles
White Papers
Products
All Star Innovators
Funny Pharm

Magazine

Subscribe (print)
Current Issue
Issue Archive

Site Tools

Site Map
Resource Directory

Stay Connected

My Account
Events Calendar
E-Newsletters
Human Interest
Facebook
Twitter
LinkedIn
YouTube
RSS Feed

Contact Us | Advertise | Privacy Policy | Legal Disclaimers, Terms & Conditions

Copyright © 2004 - 2019 Pharma Manufacturing. All rights reserved.

P: 630-467-1300 | 1501 E. Woodfield Road, Suite 400N, Schaumburg, IL 60173

Chemical Processing | Control | Control Design | Food Processing | Pharma Manufacturing | Plant Services | Smart Industry